Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer's Disease?

22Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Neuronal cell death, amyloid β plaque formation and development of neurofibrillary tangles are among the characteristics of Alzheimer's disease (AD). In addition to neurodegeneration, inflammatory processes such as activation of microglia and astrocytes are crucial in the pathogenesis and progression of AD. Cytokines are essential immune mediators of the immune response in AD. Recent data suggest a role of interleukin 23 (IL-23) and its p40 subunit in the pathogenesis of AD and corresponding animal models, in particular concerning microglia activation and amyloid β plaque formation. Moreover, in animal models, the injection of anti-p40 antibodies resulted in reduced amyloid β plaque formation and improved cognitive performance. Here, we discuss the pathomechanism of IL-23 mediated inflammation and its role in AD.

Cite

CITATION STYLE

APA

Nitsch, L., Schneider, L., Zimmermann, J., & Müller, M. (2021, April 7). Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer’s Disease? Frontiers in Neurology. Frontiers Media S.A. https://doi.org/10.3389/fneur.2021.639353

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free